South West Ventures Fund and Finance South West Growth Fund have led a £2.1m further funding round in Bath-based company, Atlas Genetics.This latest round sees further funding being provided by existing investors, South West Ventures Fund, GEIF and private investors through the SWAIN business angel’s network. New investors in the round are the Finance South West Growth Fund and Braveheart Ventures. The business is developing a ‘point of care’ molecular diagnostic platform that gives clinicians results in less than 30 minutes from taking the patient sample. The company is currently working on tests for meningitis, Chlamydia, Group B Streptococcus and the hospital “super-bug” MRSA.
Belgian GP plans to back the company, according to a document by the Dutch competition authority
Fresh capital will be used to accelerate Funnel's operations in the US and invest in its technical teams
MACSF co-invested with the GP in a spin-off from Vocalcom Group, an Apax France portfolio company
Marston is a judicial services group, which recovers funds on behalf of taxpayers and businesses